These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2093839)

  • 21. Fluconazole-resistant Candida species in the oral flora of fluconazole-exposed HIV-positive patients.
    Hunter KD; Gibson J; Lockhart P; Pithie A; Bagg J
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 May; 85(5):558-64. PubMed ID: 9619674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis.
    Johnson EM; Warnock DW; Luker J; Porter SR; Scully C
    J Antimicrob Chemother; 1995 Jan; 35(1):103-14. PubMed ID: 7768758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Itraconazole cyclodextrin solution for fluconazole-refractory oropharyngeal candidiasis in AIDS: correlation of clinical response with in vitro susceptibility.
    Phillips P; Zemcov J; Mahmood W; Montaner JS; Craib K; Clarke AM
    AIDS; 1996 Oct; 10(12):1369-76. PubMed ID: 8902066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of in vitro fluconazole susceptibility with clinical outcome for severely ill patients with oropharyngeal candidiasis.
    Arikan S; Akova M; Hayran M; Ozdemir O; Erman M; Gür D; Unal S
    Clin Infect Dis; 1998 Apr; 26(4):903-8. PubMed ID: 9564473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance.
    Sangeorzan JA; Bradley SF; He X; Zarins LT; Ridenour GL; Tiballi RN; Kauffman CA
    Am J Med; 1994 Oct; 97(4):339-46. PubMed ID: 7942935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluconazole orally dispersible tablets for the treatment of patients with oropharyngeal candidiasis.
    Vandercam B; Gibbs D; Valtonen M; Jäger H; Armignacco O
    J Int Med Res; 1998; 26(4):209-18. PubMed ID: 9818788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of sargramostim (rh-GM-CSF) as adjunctive treatment of fluconazole-refractory oropharyngeal candidiasis in patients with AIDS: a pilot study.
    Vazquez JA; Hidalgo JA; De Bono S
    HIV Clin Trials; 2000; 1(3):23-9. PubMed ID: 11590502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Oral amphotericin B inefficacy in the treatment of fluconazole++ resistant oropharyngeal candidiasis in HIV-positive patients].
    Laguna F; Valencia E; Polo R; Moreno V; González-Lahoz JM
    Rev Clin Esp; 1996 Dec; 196(12):878-9. PubMed ID: 9132869
    [No Abstract]   [Full Text] [Related]  

  • 29. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis.
    Martínez M; López-Ribot JL; Kirkpatrick WR; Bachmann SP; Perea S; Ruesga MT; Patterson TF
    J Antimicrob Chemother; 2002 Mar; 49(3):515-24. PubMed ID: 11864952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fluconazole sensitivity of Candida strains in vitro in the microdilution test and agar diffusion test].
    Metzger S; Jäger H; Hofmann H
    Mycoses; 1994; 37 Suppl 1():64-70. PubMed ID: 7854369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis.
    Oude Lashof AM; De Bock R; Herbrecht R; de Pauw BE; Krcmery V; Aoun M; Akova M; Cohen J; Siffnerová H; Egyed M; Ellis M; Marinus A; Sylvester R; Kullberg BJ;
    Eur J Cancer; 2004 Jun; 40(9):1314-9. PubMed ID: 15177489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and mycological responses to fluconazole and fluconazole MIC in oropharyngeal candidiasis in HIV-infected patients.
    Bussaratid V; Tansupasawasdikul S; Simpson A; Pitisuttithum P; Phonrat B; Howe P; White NJ
    J Med Assoc Thai; 2002 Jul; 85(7):757-64. PubMed ID: 12296406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between in vitro resistance to fluconazole and clinical outcome of oropharyngeal candidiasis in HIV-infected patients.
    Quereda C; Polanco AM; Giner C; Sánchez-Sousa A; Pereira E; Navas E; Fortún J; Guerrero A; Baquero F
    Eur J Clin Microbiol Infect Dis; 1996 Jan; 15(1):30-7. PubMed ID: 8641300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exfoliative cheilitis (EC) in AIDS: association with Candida infection.
    Reichart PA; Weigel D; Schmidt-Westhausen A; Pohle HD
    J Oral Pathol Med; 1997 Jul; 26(6):290-3. PubMed ID: 9234190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluconazole-resistant Candida in AIDS patients. Report of two cases.
    Heinic GS; Stevens DA; Greenspan D; MacPhail LA; Dodd CL; Stringari S; Strull WM; Hollander H
    Oral Surg Oral Med Oral Pathol; 1993 Dec; 76(6):711-5. PubMed ID: 8284074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of fluconazole oral suspension and amphotericin B oral suspension in older patients with oropharyngeal candidosis. Multicentre Study Group.
    Taillandier J; Esnault Y; Alemanni M
    Age Ageing; 2000 Mar; 29(2):117-23. PubMed ID: 10791445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Point prevalence of oropharyngeal carriage of fluconazole-resistant Candida in human immunodeficiency virus-infected patients.
    Martins MD; Lozano-Chiu M; Rex JH
    Clin Infect Dis; 1997 Oct; 25(4):843-6. PubMed ID: 9356799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral Candida dubliniensis as a clinically important species in HIV-seropositive patients in the United States.
    Meiller TF; Jabra-Rizk MA; Baqui Aa; Kelley JI; Meeks VI; Merz WG; Falkler WA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Nov; 88(5):573-80. PubMed ID: 10556752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.